Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Subtilisin/kexin type 9 inhibitor PubMed PubMed

Cross References

Resources Reference
ChEMBL CHEMBL2109539